Biotech Firm Illumina Fell 15% In 5 Days – Should You Sell?

Illumina’s stock dropped nearly 15% in the last 5 trading days while the S&P 500 barely moved. It appears more of a market correction driven by profit taking, considering that the stock has gone up this year despite shrinking sales. So what happens next? Is this a time to get out, or is this…

About the Author

has written 23527 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com